Abstract:Fe-based metal-organic frameworks (MOFs) can be used for chemodynamic therapy (CDT) for tumors due to their unique Fenton-like effects and porous and biodegradable natures. However, the therapeutic effects of using CDT alone are limited. Herein, MnO2@NH2-MIL101(Fe)@Ce6-F127 nanoparticles (MNMCF NPs) were synthesized by a facile solvothermal strategy. When reached the tumor sites, the MNMCF NPs could undergo a Fenton-like reaction, producing •OH and showing CDT effects. MnO2 specifically could respond to produce O2 in the tumor microenvironment, thereby improving the tumor hypoxia state and enhancing the efficacy of photodynamic therapy (PDT) by Ce6. Both the in-vitro and in-vivo experiments showed that the MNMCF-guided CDT/PDT combination therapy could effectively ablate tumors. Therefore, the prepared MNMCF NPs can be used as a promising candidate for synergistic CDT/PDT antitumor therapy.

MOF(Fe)-derived composites as a unique nanoplatform for chemo-photodynamic tumor therapy